Testing effectiveness (Phase 2)Study completedNCT00218465
What this trial is testing
Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking
Who this might be right for
Nicotine Dependence
Massachusetts General Hospital 264